市場調査レポート

商品コード

1630979

無血清培地の世界市場：市場規模・シェア・動向分析 (溶液別・製品別・最終用途別・種類別・地域別・セグメント別、2025年～2030年)

Serum-free Media Market Size, Share & Trends Analysis Report By Solution, By Product, By Application (Biopharmaceutical Production, Tissue Engineering), By End-use, By Type, By Region, And Segment Forecasts, 2025 - 2030

出版日: 2024年12月03日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日

カスタマイズ可能

価格

Unprintable PDF (Single User License)

USD 5,950 854,241円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストはできません。PDFの印刷もできません。

Printable PDF (5-User License)

USD 6,950 997,811円

レポートPDFを同一企業内の同一部署における5名様までの方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

Printable PDF (Enterprise License)

USD 8,950 1,284,951円

レポートPDFの購入企業、およびその子会社、関連会社の方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

無血清培地市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の無血清培地の市場規模は、2025年から2030年にかけて13.7%のCAGRを記録し、2030年には40億5,000万米ドルに達すると予測されています。

感染症や慢性疾患の有病率の上昇と細胞ベースの治療薬への注目の高まりが相まって、市場の成長見通しが高まっています。加えて、無血清培地市場を牽引している主な要因は、細胞ベースの研究に対する資金提供の増加です。

無血清培地の使用は過去15年間にかなり増加しました。これは主に工業的用途において言えることで、バイオ医薬品の製造中に血清を使用することは、安全性へのリスクや不要な汚染の原因となります。さらに、無血清細胞培養培地は、未知の培養成分の数を減らし、未知の成長因子、ホルモン、ビタミンの影響を減らすことで、実験の安定性を向上させます。

加えて、無血清培地には、血清のバッチ検査にかかるコストや不便さを軽減し、世界の供給変動の不確実性を排除し、下流の処理や精製を簡素化するなど、数多くの利点があり、これも市場成長を促進する大きな要因となっています。

CAR T細胞療法は血液学的悪性腫瘍の治療において画期的な進歩を遂げましたが、その製造の複雑さと費用によって患者へのアクセスが制約されています。CAR-T製剤の有効性だけでなく、CAR T細胞製造の難しさの一つは、遺伝子導入後に利用可能になったT細胞の一定の増殖を達成することです。したがって、T細胞増殖を刺激する培地を最適化することは、最も重要な要素の一つです。

しかし、規制の品質基準を満たしながら一定の増殖を可能にする培地を作ることは、困難であることが証明されています。しかし、細胞培養技術の新たな開発により、無血清培地を利用したCAR T細胞ワークフローにおける生産量と機能性が向上し、数十億個のT細胞を迅速に生産できる、規制に準拠した大規模プロセスの構築が可能になった。

例えば、アフリカミドリザルの腎臓に由来するVero細胞株は、ウイルスワクチンの製造に広く応用されてきました。さらに、いくつかのSARS-CoV変異体の製造にも利用されています。例えば、ロンザ・バイオサイエンスのProVeroTM1血清フリー培地は、Vero細胞やMDCKの開発をサポートすることを目的とした、タンパク質を含まない非動物由来の培地です。さらに、HiMedia Labs社製のHEKin1は、組換えSARS-CoV-2スパイク（S）糖タンパク質を含むCOVID-19ワクチンであるCOVISHIELDの製造に使用されました。このワクチンは遺伝子組み換えHEK293細胞を用いて製造されました。

一方、血清培地と比較してSFMの増殖速度が遅いこと、特定の培地製剤を調製するために異なる細胞タイプが必要であること、継代時に細胞が凝集することが抑制要因となり得ます。

無血清培地市場レポートハイライト

製品別では、CHO培地が市場を独占し、2024年には30.9%のシェアを占めています。
用途別では、バイオ医薬品生産が市場をリードし、2024年の売上シェアは73.7%。
最終用途別では、製薬・バイオテクノロジー企業が2024年に57.9%の最大収益シェアを占めました。これらの企業は、細胞培養のための制御された明確な環境を維持するために無血清培地を必要としており、それによって製品の品質と一貫性を高めています。
タイプ別では、液体培地が2024年に63.1％の収益シェアで市場を独占しました。
北米の無血清培地市場は、2024年の売上高シェア38.6%で世界市場を独占しました。北米は、強固なヘルスケアインフラ、充実したバイオ医薬品への投資、業界リーダーの集中を特徴とします。
アジア太平洋の無血清培地市場は、予測期間中に16.9％の最速CAGRを記録すると予想されます。この地域の諸国は、慢性疾患など深刻化するヘルスケアの課題に取り組むため、革新的な治療法やワクチンの開発を優先しています。

市場シェア：地域別 (2024年・2030年)
地域別ダッシュボード
市場規模の予測と動向分析 (2018～2030年)
北米
- 国別 (2018～2030年)
- 米国
- カナダ
- メキシコ
欧州
- 国別 (2018～2030年)
- 英国
- ドイツ
- フランス
- イタリア
- スペイン
- ノルウェー
- デンマーク
- スウェーデン
アジア太平洋
- 国別 (2018～2030年)
- 日本
- 中国
- インド
- 韓国
- オーストラリア
- タイ
ラテンアメリカ
- 国別 (2018～2030年)
- ブラジル
- アルゼンチン
中東・アフリカ
- 国別 (2018～2030年)
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- クウェート

第9章競合情勢

参加者概要
企業の市況分析
企業分類
戦略マッピング
企業プロファイル/上場企業
- Thermo Fisher Scientific Inc.
- Sartorius AG
- Merck KGaA
- Lonza
- Danaher Corporation
- FUJIFILM Holdings Corporation
- MP BIOMEDICALS
- Corning Incorporated
- PAN-Biotech
- R&D Systems, Inc

図表

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global serum-free media market, by region, 2018 - 2030 (USD Million)
Table 4 Global serum-free media market, by product, 2018 - 2030 (USD Million)
Table 5 Global serum-free media market, by application, 2018 - 2030 (USD Million)
Table 6 Global serum-free media market, by end use, 2018 - 2030 (USD Million)
Table 7 Global serum-free media market, by type, 2018 - 2030 (USD Million)
Table 8 North America serum-free media market, by country, 2018 - 2030 (USD Million)
Table 9 North America serum-free media market, by product, 2018 - 2030 (USD Million)
Table 10 North America serum-free media market, by application, 2018 - 2030 (USD Million)
Table 11 North America serum-free media market, by end use, 2018 - 2030 (USD Million)
Table 12 North America serum-free media market, by type, 2018 - 2030 (USD Million)
Table 13 U.S. serum-free media market, by product, 2018 - 2030 (USD Million)
Table 14 U.S. serum-free media market, by application, 2018 - 2030 (USD Million)
Table 15 U.S. serum-free media market, by end use, 2018 - 2030 (USD Million)
Table 16 U.S. serum-free media market, by type, 2018 - 2030 (USD Million)
Table 17 Canada serum-free media market, by product, 2018 - 2030 (USD Million)
Table 18 Canada serum-free media market, by application, 2018 - 2030 (USD Million)
Table 19 Canada serum-free media market, by end use, 2018 - 2030 (USD Million)
Table 20 Canada serum-free media market, by type, 2018 - 2030 (USD Million)
Table 21 Mexico serum-free media market, by product, 2018 - 2030 (USD Million)
Table 22 Mexico serum-free media market, by application, 2018 - 2030 (USD Million)
Table 23 Mexico serum-free media market, by end use, 2018 - 2030 (USD Million)
Table 24 Mexico serum-free media market, by type, 2018 - 2030 (USD Million)
Table 25 Europe serum-free media market, by country, 2018 - 2030 (USD Million)
Table 26 Europe serum-free media market, by product, 2018 - 2030 (USD Million)
Table 27 Europe serum-free media market, by application, 2018 - 2030 (USD Million)
Table 28 Europe serum-free media market, by end use, 2018 - 2030 (USD Million)
Table 29 Europe serum-free media market, by type, 2018 - 2030 (USD Million)
Table 30 UK serum-free media market, by product, 2018 - 2030 (USD Million)
Table 31 UK serum-free media market, by application, 2018 - 2030 (USD Million)
Table 32 UK serum-free media market, by end use, 2018 - 2030 (USD Million)
Table 33 UK serum-free media market, by type, 2018 - 2030 (USD Million)
Table 34 Germany serum-free media market, by product, 2018 - 2030 (USD Million)
Table 35 Germany serum-free media market, by application, 2018 - 2030 (USD Million)
Table 36 Germany serum-free media market, by end use, 2018 - 2030 (USD Million)
Table 37 Germany serum-free media market, by type, 2018 - 2030 (USD Million)
Table 38 France serum-free media market, by product, 2018 - 2030 (USD Million)
Table 39 France serum-free media market, by application, 2018 - 2030 (USD Million)
Table 40 France serum-free media market, by end use, 2018 - 2030 (USD Million)
Table 41 France serum-free media market, by type, 2018 - 2030 (USD Million)
Table 42 Italy serum-free media market, by product, 2018 - 2030 (USD Million)
Table 43 Italy serum-free media market, by application, 2018 - 2030 (USD Million)
Table 44 Italy serum-free media market, by end use, 2018 - 2030 (USD Million)
Table 45 Italy serum-free media market, by type, 2018 - 2030 (USD Million)
Table 46 Spain serum-free media market, by product, 2018 - 2030 (USD Million)
Table 47 Spain serum-free media market, by application, 2018 - 2030 (USD Million)
Table 48 Spain serum-free media market, by end use, 2018 - 2030 (USD Million)
Table 49 Spain serum-free media market, by type, 2018 - 2030 (USD Million)
Table 50 Denmark serum-free media market, by product, 2018 - 2030 (USD Million)
Table 51 Denmark serum-free media market, by application, 2018 - 2030 (USD Million)
Table 52 Denmark serum-free media market, by end use, 2018 - 2030 (USD Million)
Table 53 Denmark serum-free media market, by type, 2018 - 2030 (USD Million)
Table 54 Sweden serum-free media market, by product, 2018 - 2030 (USD Million)
Table 55 Sweden serum-free media market, by application, 2018 - 2030 (USD Million)
Table 56 Sweden serum-free media market, by end use, 2018 - 2030 (USD Million)
Table 57 Sweden serum-free media market, by type, 2018 - 2030 (USD Million)
Table 58 Norway serum-free media market, by product, 2018 - 2030 (USD Million)
Table 59 Norway serum-free media market, by application, 2018 - 2030 (USD Million)
Table 60 Norway serum-free media market, by end use, 2018 - 2030 (USD Million)
Table 61 Norway serum-free media market, by type, 2018 - 2030 (USD Million)
Table 62 Asia Pacific serum-free media market, by country, 2018 - 2030 (USD Million)
Table 63 Asia Pacific serum-free media market, by product, 2018 - 2030 (USD Million)
Table 64 Asia Pacific serum-free media market, by application, 2018 - 2030 (USD Million)
Table 65 Asia Pacific serum-free media market, by end use, 2018 - 2030 (USD Million)
Table 66 Asia Pacific serum-free media market, by type, 2018 - 2030 (USD Million)
Table 67 China serum-free media market, by product, 2018 - 2030 (USD Million)
Table 68 China serum-free media market, by application, 2018 - 2030 (USD Million)
Table 69 China serum-free media market, by end use, 2018 - 2030 (USD Million)
Table 70 China serum-free media market, by type, 2018 - 2030 (USD Million)
Table 71 Japan serum-free media market, by product, 2018 - 2030 (USD Million)
Table 72 Japan serum-free media market, by application, 2018 - 2030 (USD Million)
Table 73 Japan serum-free media market, by end use, 2018 - 2030 (USD Million)
Table 74 Japan serum-free media market, by type, 2018 - 2030 (USD Million)
Table 75 India serum-free media market, by product, 2018 - 2030 (USD Million)
Table 76 India serum-free media market, by application, 2018 - 2030 (USD Million)
Table 77 India serum-free media market, by end use, 2018 - 2030 (USD Million)
Table 78 India serum-free media market, by type, 2018 - 2030 (USD Million)
Table 79 Australia serum-free media market, by product, 2018 - 2030 (USD Million)
Table 80 Australia serum-free media market, by application, 2018 - 2030 (USD Million)
Table 81 Australia serum-free media market, by end use, 2018 - 2030 (USD Million)
Table 82 Australia serum-free media market, by type, 2018 - 2030 (USD Million)
Table 83 South Korea serum-free media market, by product, 2018 - 2030 (USD Million)
Table 84 South Korea serum-free media market, by application, 2018 - 2030 (USD Million)
Table 85 South Korea serum-free media market, by end use, 2018 - 2030 (USD Million)
Table 86 South Korea serum-free media market, by type, 2018 - 2030 (USD Million)
Table 87 Thailand serum-free media market, by product, 2018 - 2030 (USD Million)
Table 88 Thailand serum-free media market, by application, 2018 - 2030 (USD Million)
Table 89 Thailand serum-free media market, by end use, 2018 - 2030 (USD Million)
Table 90 Thailand serum-free media market, by type, 2018 - 2030 (USD Million)
Table 91 Latin America serum-free media market, by country, 2018 - 2030 (USD Million)
Table 92 Latin America serum-free media market, by product, 2018 - 2030 (USD Million)
Table 93 Latin America serum-free media market, by application, 2018 - 2030 (USD Million)
Table 94 Latin America serum-free media market, by end use, 2018 - 2030 (USD Million)
Table 95 Latin America serum-free media market, by type, 2018 - 2030 (USD Million)
Table 96 Brazil serum-free media market, by product, 2018 - 2030 (USD Million)
Table 97 Brazil serum-free media market, by application, 2018 - 2030 (USD Million)
Table 98 Brazil serum-free media market, by end use, 2018 - 2030 (USD Million)
Table 99 Brazil serum-free media market, by type, 2018 - 2030 (USD Million)
Table 100 Argentina serum-free media market, by product, 2018 - 2030 (USD Million)
Table 101 Argentina serum-free media market, by application, 2018 - 2030 (USD Million)
Table 102 Argentina serum-free media market, by end use, 2018 - 2030 (USD Million)
Table 103 Argentina serum-free media market, by type, 2018 - 2030 (USD Million)
Table 104 Middle East & Africa Serum-free media market, by country, 2018 - 2030 (USD Million)
Table 105 Middle East & Africa serum-free media market, by product, 2018 - 2030 (USD Million)
Table 106 Middle East & Africa serum-free media market, by application, 2018 - 2030 (USD Million)
Table 107 Middle East & Africa serum-free media market, by end use, 2018 - 2030 (USD Million)
Table 108 Middle East & Africa serum-free media market, by type, 2018 - 2030 (USD Million)
Table 109 South Africa serum-free media market, by product, 2018 - 2030 (USD Million)
Table 110 South Africa serum-free media market, by application, 2018 - 2030 (USD Million)
Table 111 South Africa serum-free media market, by end use, 2018 - 2030 (USD Million)
Table 112 South Africa serum-free media market, by type, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia serum-free media market, by product, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia serum-free media market, by application, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia serum-free media market, by end use, 2018 - 2030 (USD Million)
Table 116 Saudi Arabia serum-free media market, by type, 2018 - 2030 (USD Million)
Table 117 UAE serum-free media market, by product, 2018 - 2030 (USD Million)
Table 118 UAE serum-free media market, by application, 2018 - 2030 (USD Million)
Table 119 UAE serum-free media market, by end use, 2018 - 2030 (USD Million)
Table 120 UAE serum-free media market, by type, 2018 - 2030 (USD Million)
Table 121 Kuwait serum-free media market, by product, 2018 - 2030 (USD Million)
Table 122 Kuwait serum-free media market, by application, 2018 - 2030 (USD Million)
Table 123 Kuwait serum-free media market, by end use, 2018 - 2030 (USD Million)
Table 124 Kuwait serum-free media market, by type, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Serum-free media market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Product and application outlook (USD Million)
Fig. 10 End use and type outlook (USD Million)
Fig. 11 Competitive landscape
Fig. 12 Serum-free media market dynamics
Fig. 13 Serum-free media market: Porter's five forces analysis
Fig. 14 Serum-free media market: PESTLE analysis
Fig. 15 Serum-free media market: Product segment dashboard
Fig. 16 Serum-free media market: Product market share analysis, 2024 & 2030
Fig. 17 CHO media market, 2018 - 2030 (USD Million)
Fig. 18 HEK 293 media market, 2018 - 2030 (USD Million)
Fig. 19 BHK medium market, 2018 - 2030 (USD Million)
Fig. 20 Vero medium market, 2018 - 2030 (USD Million)
Fig. 21 Stem cell medium market, 2018 - 2030 (USD Million)
Fig. 22 Other serum-free media market, 2018 - 2030 (USD Million)
Fig. 23 Serum-free media market: Application segment dashboard
Fig. 24 Serum-free media market: Application market share analysis, 2024 & 2030
Fig. 25 Biopharmaceutical production market, 2018 - 2030 (USD Million)
Fig. 26 Monoclonal antibodies market, 2018 - 2030 (USD Million)
Fig. 27 Vaccines production market, 2018 - 2030 (USD Million)
Fig. 28 Other therapeutic proteins market, 2018 - 2030 (USD Million)
Fig. 29 Tissue engineering & regenerative medicine market, 2018 - 2030 (USD Million)
Fig. 30 Serum-free media market: End use segment dashboard
Fig. 31 Serum-free media market: End use market share analysis, 2024 & 2030
Fig. 32 Pharmaceutical & biotechnology companies market, 2018 - 2030 (USD Million)
Fig. 33 Research & academic institutes market, 2018 - 2030 (USD Million)
Fig. 34 Others market, 2018 - 2030 (USD Million)
Fig. 35 Serum-free media market: Type segment dashboard
Fig. 36 Serum-free media market: Type market share analysis, 2024 & 2030
Fig. 37 Liquid media market, 2018 - 2030 (USD Million)
Fig. 38 Semi-solid & solid media market, 2018 - 2030 (USD Million)
Fig. 39 Serum-free media market revenue, by region
Fig. 40 Regional marketplace: Key takeaways
Fig. 41 Regional marketplace: Key takeaways
Fig. 42 North America serum-free media market, 2018 - 2030 (USD Million)
Fig. 43 U.S. country dynamics
Fig. 44 U.S. serum-free media market, 2018 - 2030 (USD Million)
Fig. 45 Canada country dynamics
Fig. 46 Canada serum-free media market, 2018 - 2030 (USD Million)
Fig. 47 Mexico country dynamics
Fig. 48 Mexico serum-free media market, 2018 - 2030 (USD Million)
Fig. 49 Europe serum-free media market, 2018 - 2030 (USD Million)
Fig. 50 UK country dynamics
Fig. 51 UK serum-free media market, 2018 - 2030 (USD Million)
Fig. 52 Germany country dynamics
Fig. 53 Germany serum-free media market, 2018 - 2030 (USD Million)
Fig. 54 France country dynamics
Fig. 55 France serum-free media market, 2018 - 2030 (USD Million)
Fig. 56 Italy country dynamics
Fig. 57 Italy serum-free media market, 2018 - 2030 (USD Million)
Fig. 58 Spain country dynamics
Fig. 59 Spain serum-free media market, 2018 - 2030 (USD Million)
Fig. 60 Norway country dynamics
Fig. 61 Norway serum-free media market, 2018 - 2030 (USD Million)
Fig. 62 Sweden country dynamics
Fig. 63 Sweden serum-free media market, 2018 - 2030 (USD Million)
Fig. 64 Denmark country dynamics
Fig. 65 Denmark serum-free media market, 2018 - 2030 (USD Million)
Fig. 66 Asia Pacific serum-free media market, 2018 - 2030 (USD Million)
Fig. 67 Japan country dynamics
Fig. 68 Japan serum-free media market, 2018 - 2030 (USD Million)
Fig. 69 China country dynamics
Fig. 70 China serum-free media market, 2018 - 2030 (USD Million)
Fig. 71 India country dynamics
Fig. 72 India serum-free media market, 2018 - 2030 (USD Million)
Fig. 73 Australia country dynamics
Fig. 74 Australia serum-free media market, 2018 - 2030 (USD Million)
Fig. 75 South Korea country dynamics
Fig. 76 South Korea serum-free media market, 2018 - 2030 (USD Million)
Fig. 77 Thailand country dynamics
Fig. 78 Thailand serum-free media market, 2018 - 2030 (USD Million)
Fig. 79 Latin America serum-free media market, 2018 - 2030 (USD Million)
Fig. 80 Brazil country dynamics
Fig. 81 Brazil serum-free media market, 2018 - 2030 (USD Million)
Fig. 82 Argentina country dynamics
Fig. 83 Argentina serum-free media market, 2018 - 2030 (USD Million)
Fig. 84 MEA serum-free media market, 2018 - 2030 (USD Million)
Fig. 85 South Africa country dynamics
Fig. 86 South Africa serum-free media market, 2018 - 2030 (USD Million)
Fig. 87 Saudi Arabia country dynamics
Fig. 88 Saudi Arabia serum-free media market, 2018 - 2030 (USD Million)
Fig. 89 UAE country dynamics
Fig. 90 UAE serum-free media market, 2018 - 2030 (USD Million)
Fig. 91 Kuwait country dynamics
Fig. 92 Kuwait serum-free media market, 2018 - 2030 (USD Million)
Fig. 93 Company categorization
Fig. 94 Company market position analysis
Fig. 95 Strategic framework

Product Code: GVR-4-68040-070-1

Serum-free Media Market Growth & Trends:

The global serum-free media market size is expected to reach USD 4.05 billion by 2030, registering a CAGR of 13.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of infectious and chronic diseases, coupled with the growing focus on cell-based therapeutics, is increasing the market's growth prospects. In addition, growing funding for the cell-based research is the key factor driving the serum-free media market.

The use of serum-free media has increased considerably during the past 15 years. This is mainly true in industrial applications, wherein the use of serum during the manufacturing of biopharmaceuticals poses a risk to safety and a source of unwanted contamination. Moreover, Serum-free cell culture media improves the experimental constancy by reducing the number of unknown culture components and the effects of unknown growth factors, hormones, and vitamins.

In addition, serum-free media has numerous advantages, such as reducing the cost and inconvenience of batch testing sera, eliminating the uncertainty about global supply fluctuations, and simplifying downstream processing and purification, another major factor driving the market growth.

Although CAR T-cell therapies have made breakthroughs in treating hematological malignancies, their accessibility to patients is constrained by the complexity and expense of their manufacturing. Beyond the effectiveness of your CAR-T product, one difficulty in CAR T-cell production is achieving constant growth of T cells made available following gene transfer. Therefore, optimizing the media to stimulate T-cell proliferation is one of the most important factors.

Yet, creating media that permits constant growth while meeting regulatory quality criteria has proven challenging. However, new developments in cell culture techniques have enhanced output and functionality in CAR T-cell workflows utilizing serum-free media, enabling the construction of large-scale regulatory-compliant processes capable of producing billions of T cells quickly.

For instance, the Vero cell line, which was derived from the kidney of an African green monkey, has been widely applied to the production of viral vaccines. Moreover, it has been utilized to manufacture several SARS-CoV variants. For instance, Lonza Bioscience's ProVeroTM1 Serum-free Medium is a protein-free non-animal origin medium intended to support the development of Vero cells and MDCK. In addition, HEKin1, manufactured by HiMedia Labs, was used to manufacture COVISHIELD, a COVID-19 vaccine containing recombinant SARS-CoV-2 spike (S) glycoprotein. This vaccine has been manufactured using genetically modified HEK293 cells.

On the other hand, the slow growth rate of SFM as compared to the serum media, and the requirement of different cell types to prepare specific media formulations and cell clumping when passaging can be the restraining factors.

Serum-free Media Market Report Highlights:

Based on product, CHO media dominated the market and accounted for a share of 30.9% in 2024, driven by their essential role in biopharmaceutical production.
Based on application, biopharmaceutical production led the market with a revenue share of 73.7% in 2024, owing to the need for efficient, consistent cell culture systems in drug development.
Based on end-use, pharmaceutical & biotechnology companies held the largest revenue share of 57.9% in 2024. These companies need serum-free media to maintain a controlled, defined environment for cell culture, thereby enhancing product quality and consistency.
Based on type, liquid media dominated the market with a revenue share of 63.1% in 2024, attributed to their significant advantages in cell culture applications.
North America serum-free media market dominated the global market with a revenue share of 38.6% in 2024. North America features a robust healthcare infrastructure, substantial biopharmaceutical investments, and a concentration of industry leaders.
Asia Pacific serum-free media market is expected to register the fastest CAGR of 16.9% over the forecast period. Countries in the region prioritize developing innovative therapies and vaccines to tackle escalating healthcare challenges, including chronic diseases.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. End Use
- 1.2.4. Type
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
1.6. Information Analysis
- 1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
- 1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Serum-free Media Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
  - 3.3.1.1. Supplier Power
  - 3.3.1.2. Buyer Power
  - 3.3.1.3. Substitution Threat
  - 3.3.1.4. Threat of New Entrants
  - 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTLE Analysis

Chapter 4. Serum-free Media Market: Product Business Analysis

4.1. Product Market Share, 2024 & 2030
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. CHO Media
- 4.4.1. CHO Media Market, 2018 - 2030 (USD Million)
4.5. HEK 293 Media
- 4.5.1. HEK 293 Media Market, 2018 - 2030 (USD Million)
4.6. BHK Medium
- 4.6.1. BHK Medium Market, 2018 - 2030 (USD Million)
4.7. Vero Medium
- 4.7.1. Vero Medium Market, 2018 - 2030 (USD Million)
4.8. Stem Cell Medium
- 4.8.1. Stem Cell Medium Market, 2018 - 2030 (USD Million)
4.9. Other Serum-free Media
- 4.9.1. Other Serum-free Media Market, 2018 - 2030 (USD Million)

Chapter 5. Serum-free Media Market: Application Business Analysis

5.1. Application Market Share, 2024 & 2030
5.2. Application Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Biopharmaceutical Production
- 5.4.1. Biopharmaceutical Production Market, 2018 - 2030 (USD Million)
- 5.4.2. Monoclonal Antibodies
  - 5.4.2.1. Monoclonal Antibodies Market, 2018 - 2030 (USD Million)
- 5.4.3. Vaccines Production
  - 5.4.3.1. Vaccines Production Market, 2018 - 2030 (USD Million)
- 5.4.4. Other Therapeutic Proteins
  - 5.4.4.1. Other Therapeutic Proteins Market, 2018 - 2030 (USD Million)
5.5. Tissue Engineering & Regenerative Medicine
- 5.5.1. Tissue Engineering & Regenerative Medicine Market, 2018 - 2030 (USD Million)

Chapter 6. Serum-free Media Market: End Use Business Analysis

6.1. End Use Market Share, 2024 & 2030
6.2. End Use Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Pharmaceutical & Biotechnology Companies
- 6.4.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
6.5. Research & Academic Institutes
- 6.5.1. Research & Academic Institutes Market, 2018 - 2030 (USD Million)
6.6. Others
- 6.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Serum-free Media Market: Type Business Analysis

7.1. Type Market Share, 2024 & 2030
7.2. Type Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
7.4. Liquid Media
- 7.4.1. Liquid Media Market, 2018 - 2030 (USD Million)
7.5. Semi-solid & Solid Media
- 7.5.1. Semi-solid & Solid Media Market, 2018 - 2030 (USD Million)

Chapter 8. Serum-free Media Market: Regional Estimates & Trend Analysis

8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.4. North America
- 8.4.1. North America Serum-free Media Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 8.4.2. U.S.
  - 8.4.2.1. Key Country Dynamics
  - 8.4.2.2. Regulatory Framework
  - 8.4.2.3. Competitive Insights
  - 8.4.2.4. U.S. Serum-free Media Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.4.3. Canada
  - 8.4.3.1. Key Country Dynamics
  - 8.4.3.2. Regulatory Framework
  - 8.4.3.3. Competitive Insights
  - 8.4.3.4. Canada Serum-free Media Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.4.4. Mexico
  - 8.4.4.1. Key Country Dynamics
  - 8.4.4.2. Regulatory Framework
  - 8.4.4.3. Competitive Insights
  - 8.4.4.4. Mexico Serum-free Media Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5. Europe
- 8.5.1. Europe Serum-free Media Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 8.5.2. UK
  - 8.5.2.1. Key Country Dynamics
  - 8.5.2.2. Regulatory Framework
  - 8.5.2.3. Competitive Insights
  - 8.5.2.4. UK Serum-free Media Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.3. Germany
  - 8.5.3.1. Key Country Dynamics
  - 8.5.3.2. Regulatory Framework
  - 8.5.3.3. Competitive Insights
  - 8.5.3.4. Germany Serum-free Media Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.4. France
  - 8.5.4.1. Key Country Dynamics
  - 8.5.4.2. Regulatory Framework
  - 8.5.4.3. Competitive Insights
  - 8.5.4.4. France Serum-free Media Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.5. Italy
  - 8.5.5.1. Key Country Dynamics
  - 8.5.5.2. Regulatory Framework
  - 8.5.5.3. Competitive Insights
  - 8.5.5.4. Italy Serum-free Media Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.6. Spain
  - 8.5.6.1. Key Country Dynamics
  - 8.5.6.2. Regulatory Framework
  - 8.5.6.3. Competitive Insights
  - 8.5.6.4. Spain Serum-free Media Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.7. Norway
  - 8.5.7.1. Key Country Dynamics
  - 8.5.7.2. Regulatory Framework
  - 8.5.7.3. Competitive Insights
  - 8.5.7.4. Norway Serum-free Media Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.8. Denmark
  - 8.5.8.1. Key Country Dynamics
  - 8.5.8.2. Regulatory Framework
  - 8.5.8.3. Competitive Insights
  - 8.5.8.4. Denmark Serum-free Media Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.9. Sweden
  - 8.5.9.1. Key Country Dynamics
  - 8.5.9.2. Regulatory Framework
  - 8.5.9.3. Competitive Insights
  - 8.5.9.4. Sweden Serum-free Media Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6. Asia Pacific
- 8.6.1. Asia Pacific Serum-free Media Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 8.6.2. Japan
  - 8.6.2.1. Key Country Dynamics
  - 8.6.2.2. Regulatory Framework
  - 8.6.2.3. Competitive Insights
  - 8.6.2.4. Japan Serum-free Media Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.6.3. China
  - 8.6.3.1. Key Country Dynamics
  - 8.6.3.2. Regulatory Framework
  - 8.6.3.3. Competitive Insights
  - 8.6.3.4. China Serum-free Media Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.6.4. India
  - 8.6.4.1. Key Country Dynamics
  - 8.6.4.2. Regulatory Framework
  - 8.6.4.3. Competitive Insights
  - 8.6.4.4. India Serum-free Media Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.6.5. South Korea
  - 8.6.5.1. Key Country Dynamics
  - 8.6.5.2. Regulatory Framework
  - 8.6.5.3. Competitive Insights
  - 8.6.5.4. South Korea Serum-free Media Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.6.6. Australia
  - 8.6.6.1. Key Country Dynamics
  - 8.6.6.2. Regulatory Framework
  - 8.6.6.3. Competitive Insights
  - 8.6.6.4. Australia Serum-free Media Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.6.7. Thailand
  - 8.6.7.1. Key Country Dynamics
  - 8.6.7.2. Regulatory Framework
  - 8.6.7.3. Competitive Insights
  - 8.6.7.4. Thailand Serum-free Media Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7. Latin America
- 8.7.1. Latin America Serum-free Media Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 8.7.2. Brazil
  - 8.7.2.1. Key Country Dynamics
  - 8.7.2.2. Regulatory Framework
  - 8.7.2.3. Competitive Insights
  - 8.7.2.4. Brazil Serum-free Media Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.7.3. Argentina
  - 8.7.3.1. Key Country Dynamics
  - 8.7.3.2. Regulatory Framework
  - 8.7.3.3. Competitive Insights
  - 8.7.3.4. Argentina Serum-free Media Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8. MEA
- 8.8.1. MEA Serum-free Media Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 8.8.2. South Africa
  - 8.8.2.1. Key Country Dynamics
  - 8.8.2.2. Regulatory Framework
  - 8.8.2.3. Competitive Insights
  - 8.8.2.4. South Africa Serum-free Media Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.8.3. Saudi Arabia
  - 8.8.3.1. Key Country Dynamics
  - 8.8.3.2. Regulatory Framework
  - 8.8.3.3. Competitive Insights
  - 8.8.3.4. Saudi Arabia Serum-free Media Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.8.4. UAE
  - 8.8.4.1. Key Country Dynamics
  - 8.8.4.2. Regulatory Framework
  - 8.8.4.3. Competitive Insights
  - 8.8.4.4. UAE Serum-free Media Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.8.5. Kuwait
  - 8.8.5.1. Key Country Dynamics
  - 8.8.5.2. Regulatory Framework
  - 8.8.5.3. Competitive Insights
  - 8.8.5.4. Kuwait Serum-free Media Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

9.1. Participant Overview
9.2. Company Market Position Analysis
9.3. Company Categorization
9.4. Strategy Mapping
9.5. Company Profiles/Listing
- 9.5.1. Thermo Fisher Scientific Inc.
  - 9.5.1.1. Overview
  - 9.5.1.2. Financial Performance
  - 9.5.1.3. Product Benchmarking
  - 9.5.1.4. Strategic Initiatives
- 9.5.2. Sartorius AG
  - 9.5.2.1. Overview
  - 9.5.2.2. Financial Performance
  - 9.5.2.3. Product Benchmarking
  - 9.5.2.4. Strategic Initiatives
- 9.5.3. Merck KGaA
  - 9.5.3.1. Overview
  - 9.5.3.2. Financial Performance
  - 9.5.3.3. Product Benchmarking
  - 9.5.3.4. Strategic Initiatives
- 9.5.4. Lonza
  - 9.5.4.1. Overview
  - 9.5.4.2. Financial Performance
  - 9.5.4.3. Product Benchmarking
  - 9.5.4.4. Strategic Initiatives
- 9.5.5. Danaher Corporation
  - 9.5.5.1. Overview
  - 9.5.5.2. Financial Performance
  - 9.5.5.3. Product Benchmarking
  - 9.5.5.4. Strategic Initiatives
- 9.5.6. FUJIFILM Holdings Corporation
  - 9.5.6.1. Overview
  - 9.5.6.2. Financial Performance
  - 9.5.6.3. Product Benchmarking
  - 9.5.6.4. Strategic Initiatives
- 9.5.7. MP BIOMEDICALS
  - 9.5.7.1. Overview
  - 9.5.7.2. Financial Performance
  - 9.5.7.3. Product Benchmarking
  - 9.5.7.4. Strategic Initiatives
- 9.5.8. Corning Incorporated
  - 9.5.8.1. Overview
  - 9.5.8.2. Financial Performance
  - 9.5.8.3. Product Benchmarking
  - 9.5.8.4. Strategic Initiatives
- 9.5.9. PAN-Biotech
  - 9.5.9.1. Overview
  - 9.5.9.2. Financial Performance
  - 9.5.9.3. Product Benchmarking
  - 9.5.9.4. Strategic Initiatives
- 9.5.10. R&D Systems, Inc
  - 9.5.10.1. Overview
  - 9.5.10.2. Financial Performance
  - 9.5.10.3. Product Benchmarking
  - 9.5.10.4. Strategic Initiatives

無血清培地の世界市場：市場規模・シェア・動向分析 (溶液別・製品別・最終用途別・種類別・地域別・セグメント別、2025年～2030年)

Serum-free Media Market Size, Share & Trends Analysis Report By Solution, By Product, By Application (Biopharmaceutical Production, Tissue Engineering), By End-use, By Type, By Region, And Segment Forecasts, 2025 - 2030

無血清培地市場の成長と動向：

無血清培地市場レポートハイライト

目次

第1章分析方法・範囲

第2章エグゼクティブサマリー

第3章無血清培地市場：変動要因・傾向・範囲

第4章無血清培地市場：製品別のビジネス分析

第5章無血清培地市場：用途別のビジネス分析

第6章無血清培地市場：最終用途別のビジネス分析

第7章無血清培地市場：種類別のビジネス分析

第8章無血清培地市場：地域別の推定・動向分析

第9章競合情勢

List of Tables

List of Figures

Serum-free Media Market Growth & Trends:

Serum-free Media Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Serum-free Media Market Variables, Trends, & Scope

Chapter 4. Serum-free Media Market: Product Business Analysis

Chapter 5. Serum-free Media Market: Application Business Analysis

Chapter 6. Serum-free Media Market: End Use Business Analysis

Chapter 7. Serum-free Media Market: Type Business Analysis

Chapter 8. Serum-free Media Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

無血清培地の世界市場：市場規模・シェア・動向分析 (溶液別・製品別・最終用途別・種類別・地域別・セグメント別、2025年～2030年)

Serum-free Media Market Size, Share & Trends Analysis Report By Solution, By Product, By Application (Biopharmaceutical Production, Tissue Engineering), By End-use, By Type, By Region, And Segment Forecasts, 2025 - 2030

無血清培地市場の成長と動向：

無血清培地市場レポートハイライト

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 無血清培地市場：変動要因・傾向・範囲

第4章 無血清培地市場：製品別のビジネス分析

第5章 無血清培地市場：用途別のビジネス分析

第6章 無血清培地市場：最終用途別のビジネス分析

第7章 無血清培地市場：種類別のビジネス分析

第8章 無血清培地市場：地域別の推定・動向分析

第9章 競合情勢

List of Tables

List of Figures

Serum-free Media Market Growth & Trends:

Serum-free Media Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Serum-free Media Market Variables, Trends, & Scope

Chapter 4. Serum-free Media Market: Product Business Analysis

Chapter 5. Serum-free Media Market: Application Business Analysis

Chapter 6. Serum-free Media Market: End Use Business Analysis

Chapter 7. Serum-free Media Market: Type Business Analysis

Chapter 8. Serum-free Media Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

第1章分析方法・範囲

第2章エグゼクティブサマリー

第3章無血清培地市場：変動要因・傾向・範囲

第4章無血清培地市場：製品別のビジネス分析

第5章無血清培地市場：用途別のビジネス分析

第6章無血清培地市場：最終用途別のビジネス分析

第7章無血清培地市場：種類別のビジネス分析

第8章無血清培地市場：地域別の推定・動向分析

第9章競合情勢